Author:
Beheshti Mohsen,Langsteger Werner
Publisher
Springer Berlin Heidelberg
Reference192 articles.
1. Abrahamsson P-A (2004) Pathophysiology of bone metastases in prostate cancer. Eur Urol Suppl 3(5):1–62
2. Agus DB, Golde DW, Sgouros G, Ballangrud A, Cordon-Cardo C, Scher HI (1998) Positron emission tomography of a human prostate cancer xenograft: association of changes in deoxyglucose accumulation with other measures of outcome following androgen withdrawal. Cancer Res 58(14):3009–3014
3. Alavi A, Kung JW, Zhuang H (2004) Implications of PET based molecular imaging on the current and future practice of medicine. Semin Nucl Med 34(1):56–69
4. Albrecht S, Buchegger F, Soloviev D et al (2006) (11)C-acetate PET in the early evaluation of prostate cancer recurrence. Eur J Nucl Med Mol Imaging 34(2): 185–196
5. Albrecht S, Buchegger F, Soloviev D et al (2007) (11)C-acetate PET in the early evaluation of prostate cancer recurrence. Eur J Nucl Med Mol Imaging 34(2):185–196